Lupin
Lupin: Company gets U.S. FDA approval for its Abbreviated New Drug Application for Ipratropium Bromide Nasal Solution
LUPIN Stock have a good support at 2000 levels.
#WatchOutFor#StockInNews#Today’sTradingSetup#Budget2025#IndexStrategies

Popular topics to explore
Lupin: Company gets U.S. FDA approval for its Abbreviated New Drug Application for Ipratropium Bromide Nasal Solution
LUPIN Stock have a good support at 2000 levels.
